Westphal Jeffery's Form 4 filing
Vertex, Inc. (VERX) · filed Aug 2, 2022
- Accession no.
- 0001104659-22-085259
- Filed
- Aug 2, 2022
- Trade date
- Jul 29, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market sales total $36.8M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Westphal JefferyCIK 0001818851 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2022 | Class A Common Stock | SSaleDisposed | −5,000,000 | $7.35 | −$36,750,000 | 11,300,000 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2022 | Class A Common Stock | SSaleDisposed | −750,000 | $0.00F2 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
In connection with the privately negotiated sale of shares of Class A Common Stock reported herein, the Reporting Person granted the buyer an option to purchase up to 750,000 additional shares of Class A Common Stock at a price of $7.85 per share.
Referenced by the price of 1 transaction in Table II.